Panzuto F - Search Results

1

Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study.

Sallinen VJ, Le Large TYS, Tieftrunk E, Galeev S, Kovalenko Z, Haugvik SP, Antila A, Franklin O, Martinez-Moneo E, Robinson SM, Panzuto F, Regenet N, Muffatti F, Partelli S, Wiese D, Ruszniewski P, Dousset B, Edwin B, Bartsch DK, Sauvanet A, Falconi M, Ceyhan GO, Gaujoux S; Pancreas 2000 research group. Sallinen VJ, et al. Among authors: panzuto f. HPB (Oxford). 2018 Mar;20(3):251-259. doi: 10.1016/j.hpb.2017.08.034. Epub 2017 Oct 5. HPB (Oxford). 2018. PMID: 28988702 Free article.

2

Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE).

Corleto VD, Panzuto F, Falconi M, Cannizzaro R, Angeletti S, Moretti A, Delle Fave G, Farinati F; Oncology Study Section of the Italian Society of Gastroenterology. Corleto VD, et al. Among authors: panzuto f. Dig Liver Dis. 2001 Apr;33(3):217-21. doi: 10.1016/s1590-8658(01)80710-6. Dig Liver Dis. 2001. PMID: 11407665

3

Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors.

Panzuto F, Severi C, Cannizzaro R, Falconi M, Angeletti S, Pasquali A, Corleto VD, Annibale B, Buonadonna A, Pederzoli P, Delle Fave G. Panzuto F, et al. J Endocrinol Invest. 2004 Jan;27(1):6-11. doi: 10.1007/BF03350903. J Endocrinol Invest. 2004. PMID: 15053236 Clinical Trial.

4

Gastric neuroendocrine tumors.

Delle Fave G, Capurso G, Annibale B, Panzuto F. Delle Fave G, et al. Among authors: panzuto f. Neuroendocrinology. 2004;80 Suppl 1:16-9. doi: 10.1159/000080734. Neuroendocrinology. 2004. PMID: 15477710 Review.

5

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.

Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, Di Fonzo M, Tornatore V, Milione M, Angeletti S, Cattaruzza MS, Ziparo V, Bordi C, Pederzoli P, Delle Fave G. Panzuto F, et al. Endocr Relat Cancer. 2005 Dec;12(4):1083-92. doi: 10.1677/erc.1.01017. Endocr Relat Cancer. 2005. PMID: 16322345

6

Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma.

Panzuto F, Di Fonzo M, Iannicelli E, Sciuto R, Maini CL, Capurso G, Milione M, Cattaruzza MS, Falconi M, David V, Ziparo V, Pederzoli P, Bordi C, Delle Fave G. Panzuto F, et al. Ann Oncol. 2006 Mar;17(3):461-6. doi: 10.1093/annonc/mdj113. Epub 2005 Dec 19. Ann Oncol. 2006. PMID: 16364959 Free article.

7

Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours.

Bettini R, Boninsegna L, Mantovani W, Capelli P, Bassi C, Pederzoli P, Delle Fave GF, Panzuto F, Scarpa A, Falconi M. Bettini R, et al. Among authors: panzuto f. Ann Oncol. 2008 May;19(5):903-8. doi: 10.1093/annonc/mdm552. Epub 2008 Jan 21. Ann Oncol. 2008. PMID: 18209014 Free article.

8

Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas.

Corleto VD, Falconi M, Panzuto F, Milione M, De Luca O, Perri P, Cannizzaro R, Bordi C, Pederzoli P, Scarpa A, Delle Fave G. Corleto VD, et al. Among authors: panzuto f. Neuroendocrinology. 2009;89(2):223-30. doi: 10.1159/000167796. Epub 2008 Oct 31. Neuroendocrinology. 2009. PMID: 18974627

9

Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients.

Capurso G, Falconi M, Panzuto F, Rinzivillo M, Boninsegna L, Bettini R, Corleto V, Borgia P, Pederzoli P, Scarpa A, Delle Fave G. Capurso G, et al. Among authors: panzuto f. Am J Gastroenterol. 2009 Dec;104(12):3034-41. doi: 10.1038/ajg.2009.466. Epub 2009 Aug 18. Am J Gastroenterol. 2009. PMID: 19690522

10

Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression.

Panzuto F, Boninsegna L, Fazio N, Campana D, Pia Brizzi M, Capurso G, Scarpa A, De Braud F, Dogliotti L, Tomassetti P, Delle Fave G, Falconi M. Panzuto F, et al. J Clin Oncol. 2011 Jun 10;29(17):2372-7. doi: 10.1200/JCO.2010.33.0688. Epub 2011 May 9. J Clin Oncol. 2011. PMID: 21555696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page